Status:
RECRUITING
Longitudinal Impact of Stressors in Adults With Tourette Syndrome
Lead Sponsor:
Vanderbilt University Medical Center
Collaborating Sponsors:
University of California, Los Angeles
Conditions:
Tourette Syndrome
Eligibility:
All Genders
18+ years
Brief Summary
The Investigators propose a two-year, longitudinal pilot study of TS adults (\>18) to determine impact of lifetime environmental stress exposure on tic severity, psychiatric comorbidity severity, and ...
Detailed Description
Tourette syndrome (TS) is a widely prevalent neurodevelopmental disorder with limited treatment options,(1,2) substantial impact on quality of life in children(3-7) and adults,(4,8-10) and two-fold in...
Eligibility Criteria
Inclusion
- adults (\>18) meeting Diagnostic and Statistics Manual, 5th edition (DSM-V) criteria for Tourette syndrome, chronic motor tic disorder, or chronic vocal tic disorder
- ability to provide informed consent
- English proficiency
Exclusion
- \- significant medical, neurologic, or psychiatric diagnoses (e.g. uncontrolled epilepsy, chronic heart failure, schizophrenia) besides TS and its commonly co-occurring psychiatric diagnoses
Key Trial Info
Start Date :
September 30 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2027
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT04851678
Start Date
September 30 2021
End Date
June 30 2027
Last Update
April 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vanderbilt University Medical Center
Nashville, Tennessee, United States, 37232-5400